Chapter 18 Nonfinancial and Multiple Measures of Performance McGraw-Hill/Irwin Copyright © 2011 by The McGraw-Hill Companies, Inc. All rights reserved. Learning Objectives…

1. Atlas Copco Group Q3 Results October 22, 2010 2. Q3 - highlights  Strong order growth – Sequentially higher volumes in all regions and in most customer segments –…

âSTRUCTURE BASE DRUG DESIGNâ Content Abstract Drug Aims and Objective Drug design Drug design Approaches Basic principle Challenges of drug design Types of drug design…

Slide 1 Fingolimod (Gilenya) Presented by Matthew Brickey, Tim Robinson, Tom McGinnis, and Katie Youmans Slide 2 Outline Disease: Multiple Schlerosis Discovery of Fingolimod-Gilenya…

Slide 1 A Phase III, Randomized, Double-Blind, Placebo-Controlled Registration Trial to Evaluate the Efficacy and Safety of Placebo + Trastuzumab + Docetaxel vs. Pertuzumab…

PRE-FEASIBILITY REPORT FOR PRE-FEASIBILITY REPORT FOR BHAIRAVNATH SUGAR WORKâS LTD, SONARI Highlights of Process Fermentation: · We have incorporated mechanical educator…

2007-2008 Lower GI Overview Chair: Charles D. Blanke, M.D., F.A.C.P. Systemic Therapy Provincial Program Leader, B.C. Cancer Agency Chief, Division of Medical Oncology, University…

Synthetic antimicrobial agents (人工合成抗菌药) Huifang Tang [email protected] Classification of Synthetic antimicrobial agents Ⅰ. Quinolones(喹诺酮类);…

Updated results, multivariate and subgroups analysis confirm improved activity and efficacy for FOLFOXIRI vs FOLFIRI in the G.O.N.O. randomized phase III study in metastatic…

Biapenem Biapenem (“RPX- 2003”) is a broad-spectrum carbapenem with in vitro activity against Gram-negative and Gram-positive bacteria similar to that of meropenem. Like…